Artykuły udostępnione publicznie: - M. Reza Skandari, PhDWięcej informacji
Niedostępne w żadnym miejscu: 2
Patient-type Bayes-adaptive treatment plans
MR Skandari, SM Shechter
Operations research 69 (2), 574-598, 2021
Upoważnienia: Natural Sciences and Engineering Research Council of Canada, Michael Smith …
Cost-effectiveness analysis of vascular access referral policies in CKD
SM Shechter, T Chandler, MR Skandari, N Zalunardo
American Journal of Kidney Diseases 70 (3), 368-376, 2017
Upoważnienia: Natural Sciences and Engineering Research Council of Canada, Michael Smith …
Dostępne w jakimś miejscu: 13
Revisiting the time needed to provide adult primary care
J Porter, C Boyd, MR Skandari, N Laiteerapong
Journal of general internal medicine 38 (1), 147-155, 2023
Upoważnienia: US National Institutes of Health
Cost-effectiveness of continuous glucose monitoring for adults with type 1 diabetes compared with self-monitoring of blood glucose: the DIAMOND randomized trial
W Wan, MR Skandari, A Minc, AG Nathan, A Winn, P Zarei, M O’Grady, ...
Diabetes care 41 (6), 1227-1234, 2018
Upoważnienia: US National Institutes of Health
First-line therapy for type 2 diabetes with sodium–glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a cost-effectiveness study
JG Choi, AN Winn, MR Skandari, MI Franco, EM Staab, J Alexander, ...
Annals of internal medicine 175 (10), 1392-1400, 2022
Upoważnienia: US National Institutes of Health
Individualized glycemic control for US adults with type 2 diabetes: a cost-effectiveness analysis
N Laiteerapong, JM Cooper, MR Skandari, PM Clarke, AN Winn, ...
Annals of internal medicine 168 (3), 170-178, 2018
Upoważnienia: US National Institutes of Health
The impact of biomarker screening and cascade genetic testing on the cost-effectiveness of MODY genetic testing
MS GoodSmith, MR Skandari, ES Huang, RN Naylor
Diabetes Care 42 (12), 2247-2255, 2019
Upoważnienia: US National Institutes of Health
The longer-term benefits and harms of glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis
JT Alexander, EM Staab, W Wan, M Franco, A Knitter, MR Skandari, ...
Journal of general internal medicine, 1-24, 2022
Upoważnienia: US National Institutes of Health
Cost-effectiveness of initiating an insulin pump in T1D adults using continuous glucose monitoring compared with multiple daily insulin injections: the DIAMOND randomized trial
W Wan, MR Skandari, A Minc, AG Nathan, P Zarei, AN Winn, M O’Grady, ...
Medical Decision Making 38 (8), 942-953, 2018
Upoważnienia: US National Institutes of Health
Cost-effectiveness of shared telemedicine appointments in young adults with T1D: CoYoT1 trial
W Wan, AG Nathan, MR Skandari, P Zarei, MW Reid, JK Raymond, ...
Diabetes Care 42 (8), 1589-1592, 2019
Upoważnienia: US National Institutes of Health
Optimal vascular access choice for patients on hemodialysis
MR Skandari, SM Shechter, N Zalunardo
Manufacturing & Service Operations Management 17 (4), 608-619, 2015
Upoważnienia: Natural Sciences and Engineering Research Council of Canada
Longer-term benefits and risks of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a systematic review and meta-analysis
JT Alexander, EM Staab, W Wan, M Franco, A Knitter, MR Skandari, ...
Journal of general internal medicine, 1-10, 2022
Upoważnienia: US National Institutes of Health
Development and validation of a decision analytical model for posttreatment surveillance for patients with oropharyngeal carcinoma
V Nair, S Auger, S Kochanny, FM Howard, D Ginat, O Pasternak-Wise, ...
JAMA Network Open 5 (4), e227240-e227240, 2022
Upoważnienia: US National Institutes of Health
Expected health benefits of SGLT-2 inhibitors and GLP-1 receptor agonists in older adults
RS Dadwani, W Wan, MR Skandari, ES Huang
MDM Policy & Practice 8 (2), 23814683231187566, 2023
Upoważnienia: US National Institutes of Health
Alternative type 2 diabetes screening tests may reduce the number of US adults with undiagnosed diabetes
RS Dadwani, MR Skandari, MS GoodSmith, LS Phillips, MK Rhee, ...
Diabetic Medicine 37 (11), 1935-1943, 2020
Upoważnienia: US National Institutes of Health, US Department of Veterans Affairs
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy